{"pmid":32360083,"pmcid":"PMC7195129","title":"Modulation of Hb-O2 affinity to improve hypoxemia in COVID-19 patients.","text":["Modulation of Hb-O2 affinity to improve hypoxemia in COVID-19 patients.","This opinion paper aims at discussing the potential impact of modulating the Hb-O2 affinity by the nutritional supplement 5-HMF on patients affected by COVID-19. The paper describes the critical role of the oxygen affinity in hypoxemic COVID-19 patients and the potential positive effect of 5-HMF, a compound shown to increase the Hb-O2 affinity.","Clin Nutr","Woyke, Simon","Rauch, Simon","Strohle, Mathias","Gatterer, Hannes","32360083"],"abstract":["This opinion paper aims at discussing the potential impact of modulating the Hb-O2 affinity by the nutritional supplement 5-HMF on patients affected by COVID-19. The paper describes the critical role of the oxygen affinity in hypoxemic COVID-19 patients and the potential positive effect of 5-HMF, a compound shown to increase the Hb-O2 affinity."],"journal":"Clin Nutr","authors":["Woyke, Simon","Rauch, Simon","Strohle, Mathias","Gatterer, Hannes"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360083","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.clnu.2020.04.036","keywords":["5-hydroxymethylfurfural","covid-19","nutritional supplement"],"topics":["Mechanism"],"weight":1,"_version_":1666138495877382145,"score":9.490897,"similar":[{"pmid":32453889,"title":"Haemoglobin Oxygen Affinity in Patients with Severe COVID-19 Infection.","text":["Haemoglobin Oxygen Affinity in Patients with Severe COVID-19 Infection.","During critical care, at least until the late stage of the disease, severely ill COVID-19 patients may have relatively well preserved lung compliance but remain severely hypoxaemic. A recent theoretical study suggested a direct interaction between COVID-19 viral proteins and haemoglobin (Hb) that could lead to a loss of oxygen carrying capacity. As national guidelines strongly support a restrictive transfusion strategy in the critically ill, any right-shift in the Hb O2 affinity curve could contribute to the hypoxaemia and be potentially harmful. We have measured Hb O2 affinity curves from severely ill COVID-19 patients and, in comparison to age- and sex-matched controls, find no evidence for a shift in O2 affinity that would support any change in clinical management.","Br J Haematol","Daniel, Y","Hunt, B J","Retter, A","Henderson, K","Wilson, S","Sharpe, C C","Shattock, M J","32453889"],"abstract":["During critical care, at least until the late stage of the disease, severely ill COVID-19 patients may have relatively well preserved lung compliance but remain severely hypoxaemic. A recent theoretical study suggested a direct interaction between COVID-19 viral proteins and haemoglobin (Hb) that could lead to a loss of oxygen carrying capacity. As national guidelines strongly support a restrictive transfusion strategy in the critically ill, any right-shift in the Hb O2 affinity curve could contribute to the hypoxaemia and be potentially harmful. We have measured Hb O2 affinity curves from severely ill COVID-19 patients and, in comparison to age- and sex-matched controls, find no evidence for a shift in O2 affinity that would support any change in clinical management."],"journal":"Br J Haematol","authors":["Daniel, Y","Hunt, B J","Retter, A","Henderson, K","Wilson, S","Sharpe, C C","Shattock, M J"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32453889","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/bjh.16888","topics":["Treatment"],"weight":1,"_version_":1667881798505332737,"score":321.02618},{"pmid":32475052,"title":"Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.","text":["Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.","We report detailed peptide binding affinities between 438 HLA Class I and Class II proteins and complete proteomes of seven pandemic human viruses, including coronaviruses, influenza viruses and HIV-1. We contrast these affinities with HLA allele frequencies across hundreds of human populations worldwide. Statistical modelling shows that peptide binding affinities classified into four distinct categories depend on the HLA locus but that the type of virus is only a weak predictor, except in the case of HIV-1. Amongst the strong HLA binders (IC50 </= 50), we uncovered 16 alleles (the top ones being A*02:02, B*15:03 and DRB1*01:02) binding more than 1% of peptides derived from all viruses, 9 (top ones including HLA-A*68:01, B*15:25, C*03:02 and DRB1*07:01) binding all viruses except HIV-1, and 15 (top ones A*02:01 and C*14:02) only binding coronaviruses. The frequencies of strongest and weakest HLA peptide binders differ significantly among populations from different geographic regions, with Indigenous peoples of America showing both higher frequencies of strongest and lower frequencies of weakest binders. As many HLA proteins are strong binders of peptides from distinct viral families, we discuss this result in relation to possible signatures of natural selection on HLA promiscuous alleles due to undetermined past pathogenic infections. Although highly relevant for evolutionary genetics and the development of vaccine therapies, these results should not lead to forget that individual resistance and vulnerability to diseases go beyond the sole HLA allelic affinity and depend on multiple, complex and often unknown biological, environmental and other variables. This article is protected by copyright. All rights reserved.","HLA","Barquera, Rodrigo","Collen, Evelyn","Di, Da","Buhler, Stephane","Teixeira, Joao","Llamas, Bastien","Nunes, Jose Manuel","Sanchez-Mazas, Alicia","32475052"],"abstract":["We report detailed peptide binding affinities between 438 HLA Class I and Class II proteins and complete proteomes of seven pandemic human viruses, including coronaviruses, influenza viruses and HIV-1. We contrast these affinities with HLA allele frequencies across hundreds of human populations worldwide. Statistical modelling shows that peptide binding affinities classified into four distinct categories depend on the HLA locus but that the type of virus is only a weak predictor, except in the case of HIV-1. Amongst the strong HLA binders (IC50 </= 50), we uncovered 16 alleles (the top ones being A*02:02, B*15:03 and DRB1*01:02) binding more than 1% of peptides derived from all viruses, 9 (top ones including HLA-A*68:01, B*15:25, C*03:02 and DRB1*07:01) binding all viruses except HIV-1, and 15 (top ones A*02:01 and C*14:02) only binding coronaviruses. The frequencies of strongest and weakest HLA peptide binders differ significantly among populations from different geographic regions, with Indigenous peoples of America showing both higher frequencies of strongest and lower frequencies of weakest binders. As many HLA proteins are strong binders of peptides from distinct viral families, we discuss this result in relation to possible signatures of natural selection on HLA promiscuous alleles due to undetermined past pathogenic infections. Although highly relevant for evolutionary genetics and the development of vaccine therapies, these results should not lead to forget that individual resistance and vulnerability to diseases go beyond the sole HLA allelic affinity and depend on multiple, complex and often unknown biological, environmental and other variables. This article is protected by copyright. All rights reserved."],"journal":"HLA","authors":["Barquera, Rodrigo","Collen, Evelyn","Di, Da","Buhler, Stephane","Teixeira, Joao","Llamas, Bastien","Nunes, Jose Manuel","Sanchez-Mazas, Alicia"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32475052","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/tan.13956","keywords":["covid-19","coronavirus","hiv","hla population genetics","indigenous americans","sars-cov-2","influenza","natural selection","peptide binding predictions"],"locations":["America"],"topics":["Mechanism"],"weight":1,"_version_":1668341932766527488,"score":103.98984},{"pmid":32412544,"pmcid":"PMC7220622","title":"In silico fight against novel coronavirus by finding chromone derivatives as inhibitor of coronavirus main proteases enzyme.","text":["In silico fight against novel coronavirus by finding chromone derivatives as inhibitor of coronavirus main proteases enzyme.","Novel coronavirus, 2019-nCoV is a danger to the world and is spreading rapidly. Very little structural information about 2019-nCoV make this situation more difficult for drug designing. Benzylidenechromanones, naturally occurring oxygen heterocyclic compounds, having capability to inhibit various protein and receptors, have been designed here to block mutant variety of coronavirus main protease enzyme (SARC-CoV-2 M(pro)) isolated from 2019-nCoV with the assistance of molecular docking, bioinformatics and molecular electrostatic potential. (Z)-3-(4'-chlorobenzylidene)-thiochroman-4-one showed highest binding affinity to the protein. Binding of a compound to this protein actually inhibits the replication and transcription of the virus and, ultimately, stop the virus multiplication. Incorporation of any functional groups to the basic benzylidenechromanones enhances their binding ability. Chloro and bromo substitutions amplify the binding affinity. ADME studies of all these compounds indicate they are lipophilic, high gastro intestine absorbable and blood-brain barrier permeable. The outcome reveals that the investigated benzylidenechromanones can be examined in the case of 2019-nCoV as potent inhibitory drug of SARC-CoV-2 M(pro), for their strong inhibition ability, high reactivity and effective pharmacological properties.","Struct Chem","Sepay, Nayim","Sepay, Nadir","Al Hoque, Ashique","Mondal, Rina","Halder, Umesh Chandra","Muddassir, Mohd","32412544"],"abstract":["Novel coronavirus, 2019-nCoV is a danger to the world and is spreading rapidly. Very little structural information about 2019-nCoV make this situation more difficult for drug designing. Benzylidenechromanones, naturally occurring oxygen heterocyclic compounds, having capability to inhibit various protein and receptors, have been designed here to block mutant variety of coronavirus main protease enzyme (SARC-CoV-2 M(pro)) isolated from 2019-nCoV with the assistance of molecular docking, bioinformatics and molecular electrostatic potential. (Z)-3-(4'-chlorobenzylidene)-thiochroman-4-one showed highest binding affinity to the protein. Binding of a compound to this protein actually inhibits the replication and transcription of the virus and, ultimately, stop the virus multiplication. Incorporation of any functional groups to the basic benzylidenechromanones enhances their binding ability. Chloro and bromo substitutions amplify the binding affinity. ADME studies of all these compounds indicate they are lipophilic, high gastro intestine absorbable and blood-brain barrier permeable. The outcome reveals that the investigated benzylidenechromanones can be examined in the case of 2019-nCoV as potent inhibitory drug of SARC-CoV-2 M(pro), for their strong inhibition ability, high reactivity and effective pharmacological properties."],"journal":"Struct Chem","authors":["Sepay, Nayim","Sepay, Nadir","Al Hoque, Ashique","Mondal, Rina","Halder, Umesh Chandra","Muddassir, Mohd"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32412544","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s11224-020-01537-5","keywords":["adme","benzylidenechromanones","dft","docking","novel coronavirus","sarc-cov-2 mpro"],"e_drugs":["Chromones"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666897319163854848,"score":102.3816},{"pmid":32345140,"title":"Stilbene-based Natural Compounds as Promising Drug Candidates against COVID-19.","text":["Stilbene-based Natural Compounds as Promising Drug Candidates against COVID-19.","The pandemic coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents a great threat to public health. Currently, no potent medicine is available to treat COVID-19. Quest for new drugs especially from natural plant sources is an area of immense potential. The current study aimed to repurpose stilbenoid analogs, reported for some other biological activities, against SARS-CoV-2 spike protein and human ACE2 receptor complex for their affinity and stability using molecular dynamics simulation and binding free energy analysis based on molecular docking. Four compounds in total were probed for their binding affinity using molecular docking. All of the compounds showed good affinity (> -7 kcal/mol). However, fifty nanoseconds molecular dynamic simulation in aqueous solution revealed highly stable bound conformation of resveratrol to the viral protein: ACE2 receptor complex. Net free energy of binding using MM-PBSA also affirmed the stability of the resveratrol-protein complex. Based on the results, we report that stilbene based compounds in general and resveratrol, in particular, can be promising anti-COVID-19 drug candidates acting through disruption of the spike protein. Our findings in this study are promising and call for further in vitro and in vivo testing of stiblenoids, especially resveratrol against the COVID-19.","J Biomol Struct Dyn","Wahedi, Hussain Mustatab","Ahmad, Sajjad","Abbasi, Sumra Wajid","32345140"],"abstract":["The pandemic coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents a great threat to public health. Currently, no potent medicine is available to treat COVID-19. Quest for new drugs especially from natural plant sources is an area of immense potential. The current study aimed to repurpose stilbenoid analogs, reported for some other biological activities, against SARS-CoV-2 spike protein and human ACE2 receptor complex for their affinity and stability using molecular dynamics simulation and binding free energy analysis based on molecular docking. Four compounds in total were probed for their binding affinity using molecular docking. All of the compounds showed good affinity (> -7 kcal/mol). However, fifty nanoseconds molecular dynamic simulation in aqueous solution revealed highly stable bound conformation of resveratrol to the viral protein: ACE2 receptor complex. Net free energy of binding using MM-PBSA also affirmed the stability of the resveratrol-protein complex. Based on the results, we report that stilbene based compounds in general and resveratrol, in particular, can be promising anti-COVID-19 drug candidates acting through disruption of the spike protein. Our findings in this study are promising and call for further in vitro and in vivo testing of stiblenoids, especially resveratrol against the COVID-19."],"journal":"J Biomol Struct Dyn","authors":["Wahedi, Hussain Mustatab","Ahmad, Sajjad","Abbasi, Sumra Wajid"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32345140","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1080/07391102.2020.1762743","keywords":["covid-19","mm-pbsa","molecular docking","molecular dynamic simulations","stilbene-based natural compounds"],"e_drugs":["Resveratrol","Stilbenes","poly(tetramethylene succinate-co-tetramethylene adipate)"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495020695553,"score":101.265526},{"pmid":32462996,"title":"Molecular Docking, Simulation and MM-PBSA Studies of Nigella Sativa Compounds: A Computational Quest to identify Potential Natural Antiviral for COVID-19 Treatment.","text":["Molecular Docking, Simulation and MM-PBSA Studies of Nigella Sativa Compounds: A Computational Quest to identify Potential Natural Antiviral for COVID-19 Treatment.","Nigella sativa or black seed is used as a medicinal plant around the globe. Oil and seeds have a long tradition of folklore use in various medicinal and food systems. The conventional therapeutic use of Nigella sativa, in different ways, has been reported in several studies to treat different diseases including influenza, headache, hypertension, diabetes, inflammation, eczema, fever, cough, asthma, bronchitis, and fever. Based on previously reported potential therapeutic uses of N. sativa compounds, and keeping in mind the dire need of time for the development of potent antiviral, a combined docking, ADMET properties calculation, molecular dynamics, and MM-PBSA approaches were applied in the current study to check the therapeutic potentials of N. sativa chief constituents against COVID-19. Among the studied compounds, we found that dithymoquinone (DTQ), with binding affinity of -8.6 kcal/mol compared to a positive control (chloroquine, -7.2 kcal/mol) , has the high potential of binding at SARS-CoV-2:ACE2 interface and thus could be predicted a plausible inhibitor to disrupt viral-host interactions. Molecular dynamics simulation of 100 ns well complemented binding affinity of the compound and revealed strong stability of DTQ at the docked site. Additionally, MM-PBSA also affirms the docking results. Compound DTQ of the present study, if validated in wet lab experiments, could be used to treat COVID-19 and could serve as a lead in the future for development of more effective natural antivirals against COVID-19.","J Biomol Struct Dyn","Ahmad, Sajjad","Abbasi, Hyder Wajid","Shahid, Sara","Gul, Sana","Abbasi, Sumra Wajid","32462996"],"abstract":["Nigella sativa or black seed is used as a medicinal plant around the globe. Oil and seeds have a long tradition of folklore use in various medicinal and food systems. The conventional therapeutic use of Nigella sativa, in different ways, has been reported in several studies to treat different diseases including influenza, headache, hypertension, diabetes, inflammation, eczema, fever, cough, asthma, bronchitis, and fever. Based on previously reported potential therapeutic uses of N. sativa compounds, and keeping in mind the dire need of time for the development of potent antiviral, a combined docking, ADMET properties calculation, molecular dynamics, and MM-PBSA approaches were applied in the current study to check the therapeutic potentials of N. sativa chief constituents against COVID-19. Among the studied compounds, we found that dithymoquinone (DTQ), with binding affinity of -8.6 kcal/mol compared to a positive control (chloroquine, -7.2 kcal/mol) , has the high potential of binding at SARS-CoV-2:ACE2 interface and thus could be predicted a plausible inhibitor to disrupt viral-host interactions. Molecular dynamics simulation of 100 ns well complemented binding affinity of the compound and revealed strong stability of DTQ at the docked site. Additionally, MM-PBSA also affirms the docking results. Compound DTQ of the present study, if validated in wet lab experiments, could be used to treat COVID-19 and could serve as a lead in the future for development of more effective natural antivirals against COVID-19."],"journal":"J Biomol Struct Dyn","authors":["Ahmad, Sajjad","Abbasi, Hyder Wajid","Shahid, Sara","Gul, Sana","Abbasi, Sumra Wajid"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462996","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1080/07391102.2020.1775129","keywords":["admet","covid-19","dithymoquinone","mm-pbsa","molecular dynamic simulation","nigella sativa"],"e_drugs":["Chloroquine","poly(tetramethylene succinate-co-tetramethylene adipate)","dithymoquinone"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668079521523302400,"score":97.483986}]}